RVPH Stock Price
Reviva Pharmaceuticals Holdings, Inc.
RVPH stock price is $0.48 (-3.45% on the day), giving Reviva Pharmaceuticals Holdings, Inc. a market cap of $6.49M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
RVPH Stock Overview
- Price
- $0.48
- Previous close
- $0.50
- Open
- $0.46
- Market cap
- $6.49M
- P/E ratio
- -0.3
- 52-week range
- $0.26 - $15.40
- 1-year price target
- $17.50
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 17
About Reviva Pharmaceuticals Holdings, Inc.
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of various neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. Reviva Pharmaceuticals Holdings, Inc. was founded in 2018 and is headquartered in Cupertino, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RVPH | $0.48 | -3.5% | 23.54K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Reviva Pharmaceuticals Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW